Irvine Scientific® today announced a new partnership agreement with Biotech Inc., giving Irvine Scientific exclusive distribution rights for the CRYOLOCK™ vitrification device in selected countries worldwide.

CRYOLOCK has rapidly become one of the most highly respected vitrification devices in IVF laboratories. This new partnership enables Irvine Scientific to expand its support of approved vitrification devices.

“We are confident that the addition of CRYOLOCK will allow us to support laboratories that prefer this proven and widely used device. We are excited to provide an expanded set of vitrification devices to help customers achieve exceptional results.” said Yuichi Nagano, President and CEO, Irvine Scientific.

“This partnership significantly strengthens the existing CRYOLOCK device and demonstrates Biotech Inc.’s commitment to expanding this exceptional product for use worldwide to the infertility market”, said Jorge Parra, CRYOLOCK designer and CEO, Biotech, Inc.